GeneDx announced on May 22, 2025, the publication of its article, 'AI in the Clinical Genomics Laboratory,' in the American Journal of Medical Genetics. This article, part of an essay collection by global experts, highlights GeneDx’s leadership in applying artificial intelligence (AI) to accelerate and enhance genetic diagnostics.
The publication underscores the potential of AI to increase diagnostic yield, reduce manual workflows, and scale precision medicine for patients with suspected genetic conditions. GeneDx leverages its comprehensive and clinically curated genomic and phenotypic datasets to train and deploy AI models effectively.
This strategic focus on AI, following the launch of its Multiscore AI-powered gene ranker and the acquisition of Fabric Genomics, positions GeneDx to meet the growing demand for genomic testing. The company aims to embed AI across its business, from clinical interpretation to lab operations, to deliver answers at scale and drive transformational efficiency.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.